Why the study?
Major surgery for ovarian cancer carries significant morbidity, and it was unknown whether implementing an ERAS protocol reduces postoperative complications during extensive cytoreductive surgery.
Does an Enhanced Recovery after Surgery (ERAS) protocol reduce postoperative complications and length of hospital stay in patients undergoing cytoreductive surgery for ovarian cancer?
Population
134 patients with ovarian cancer (FIGO I-IV)
Comparison
Mandatory ERAS protocol vs pre-ERAS care
Design
Prospective cohort study compared to historical controls
Key result
Implementation of a mandatory Enhanced Recovery after Surgery (ERAS) protocol significantly reduced postoperative complications (29.8% vs 52.9%) and length of hospital stay (11 vs 13 days) compared to historical controls.
Authors
Loading...
ERAS protocol was associated with fewer complications and shorter stays after ovarian cytoreduction; hypothesis-generating and requires RCTs before practice change.
Cohort (n=134)
No
Does an Enhanced Recovery after Surgery (ERAS) protocol reduce postoperative complications and length of hospital stay in patients undergoing cytoreductive surgery for ovarian cancer?
Absolute Event Rate: 29.8% vs 52.9%
p-value: p=0.011
Implementation of a mandatory ERAS protocol in patients undergoing extensive cytoreductive surgery for ovarian cancer significantly reduces postoperative complications and length of hospital stay.
Reuter et al. (2021) conducted a cohort in Ovarian cancer (n=134). Enhanced Recovery after Surgery (ERAS) protocol vs. Standard care (historical pre-ERAS cohort) was evaluated on Total number of postoperative complications (p=0.011). Implementation of a mandatory Enhanced Recovery after Surgery (ERAS) protocol significantly reduced postoperative complications (29.8% vs 52.9%) and length of hospital stay (11 vs 13 days) compared to historical controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: